questionsmedicales.fr
Sciences sociales
Sociologie
Facteurs sociologiques
Culture (sociologie)
Culture (sociologie) : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Culture (sociologie) : Questions médicales les plus fréquentes",
"headline": "Culture (sociologie) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Culture (sociologie) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-25",
"dateModified": "2025-04-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Culture (sociologie)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Facteurs sociologiques",
"url": "https://questionsmedicales.fr/mesh/D066252",
"about": {
"@type": "MedicalCondition",
"name": "Facteurs sociologiques",
"code": {
"@type": "MedicalCode",
"code": "D066252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acculturation",
"alternateName": "Acculturation",
"url": "https://questionsmedicales.fr/mesh/D000069",
"about": {
"@type": "MedicalCondition",
"name": "Acculturation",
"code": {
"@type": "MedicalCode",
"code": "D000069",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.079"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Comparaison interculturelle",
"alternateName": "Cross-Cultural Comparison",
"url": "https://questionsmedicales.fr/mesh/D003431",
"about": {
"@type": "MedicalCondition",
"name": "Comparaison interculturelle",
"code": {
"@type": "MedicalCode",
"code": "D003431",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.257"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Caractéristiques culturelles",
"alternateName": "Cultural Characteristics",
"url": "https://questionsmedicales.fr/mesh/D003466",
"about": {
"@type": "MedicalCondition",
"name": "Caractéristiques culturelles",
"code": {
"@type": "MedicalCode",
"code": "D003466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.329"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Compétence culturelle",
"alternateName": "Cultural Competency",
"url": "https://questionsmedicales.fr/mesh/D054521",
"about": {
"@type": "MedicalCondition",
"name": "Compétence culturelle",
"code": {
"@type": "MedicalCode",
"code": "D054521",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.364"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diversité culturelle",
"alternateName": "Cultural Diversity",
"url": "https://questionsmedicales.fr/mesh/D018864",
"about": {
"@type": "MedicalCondition",
"name": "Diversité culturelle",
"code": {
"@type": "MedicalCode",
"code": "D018864",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.450"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diversité, équité, inclusion",
"alternateName": "Diversity, Equity, Inclusion",
"url": "https://questionsmedicales.fr/mesh/D000092783",
"about": {
"@type": "MedicalCondition",
"name": "Diversité, équité, inclusion",
"code": {
"@type": "MedicalCode",
"code": "D000092783",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.450.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Culture populaire",
"alternateName": "Popular Culture",
"url": "https://questionsmedicales.fr/mesh/D000076207",
"about": {
"@type": "MedicalCondition",
"name": "Culture populaire",
"code": {
"@type": "MedicalCode",
"code": "D000076207",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "I01.880.853.100.628"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Culture (sociologie)",
"alternateName": "Culture",
"code": {
"@type": "MedicalCode",
"code": "D003469",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andrew Whiten",
"url": "https://questionsmedicales.fr/author/Andrew%20Whiten",
"affiliation": {
"@type": "Organization",
"name": "Centre for Social Learning and Cognitive Evolution, School of Psychology and Neuroscience, University of St Andrews, St Andrews KY16 9JP, UK. Electronic address: a.whiten@st-andrews.ac.uk."
}
},
{
"@type": "Person",
"name": "Cecilia Heyes",
"url": "https://questionsmedicales.fr/author/Cecilia%20Heyes",
"affiliation": {
"@type": "Organization",
"name": "All Souls College and Department of Experimental Psychology, University of Oxford, Oxford OX1 4AL, UK."
}
},
{
"@type": "Person",
"name": "Jung Yul Kwon",
"url": "https://questionsmedicales.fr/author/Jung%20Yul%20Kwon",
"affiliation": {
"@type": "Organization",
"name": "Arizona State University, United States. Electronic address: jungyulkwon@asu.edu."
}
},
{
"@type": "Person",
"name": "Alexandra S Wormley",
"url": "https://questionsmedicales.fr/author/Alexandra%20S%20Wormley",
"affiliation": {
"@type": "Organization",
"name": "Arizona State University, United States. Electronic address: awormley@asu.edu."
}
},
{
"@type": "Person",
"name": "Michael E W Varnum",
"url": "https://questionsmedicales.fr/author/Michael%20E%20W%20Varnum",
"affiliation": {
"@type": "Organization",
"name": "Arizona State University, United States. Electronic address: mvarnum@asu.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery Consortium.",
"datePublished": "2023-02-15",
"url": "https://questionsmedicales.fr/article/36796645",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.slasd.2023.02.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pediatric Efficacy Extrapolation in Drug Development Submitted to the US Food and Drug Administration 2015-2020.",
"datePublished": "2022-10-19",
"url": "https://questionsmedicales.fr/article/36150423",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcph.2160"
}
},
{
"@type": "ScholarlyArticle",
"name": "From target discovery to clinical drug development with human genetics.",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37612393",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41586-023-06388-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health Equity in Pediatric Drug Development: Translating Aspiration into Operation.",
"datePublished": "2022-05-20",
"url": "https://questionsmedicales.fr/article/35596108",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s43441-022-00410-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Translatability scoring in prospective and retrospective COVID drug development cases.",
"datePublished": "2023-06-06",
"url": "https://questionsmedicales.fr/article/37278822",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00228-023-03517-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Sciences sociales",
"item": "https://questionsmedicales.fr/mesh/D012942"
},
{
"@type": "ListItem",
"position": 3,
"name": "Sociologie",
"item": "https://questionsmedicales.fr/mesh/D012961"
},
{
"@type": "ListItem",
"position": 4,
"name": "Facteurs sociologiques",
"item": "https://questionsmedicales.fr/mesh/D066252"
},
{
"@type": "ListItem",
"position": 5,
"name": "Culture (sociologie)",
"item": "https://questionsmedicales.fr/mesh/D003469"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Culture (sociologie) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Culture (sociologie)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Culture (sociologie)",
"description": "Comment évaluer une culture dans un groupe social ?\nQuels outils mesurent la culture d'une organisation ?\nQuelles méthodes étudient les changements culturels ?\nComment identifier les sous-cultures ?\nQuels indicateurs montrent une culture forte ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Culture (sociologie)",
"description": "Quels signes montrent un choc culturel ?\nComment reconnaître une culture toxique ?\nQuels effets le stress culturel a-t-il ?\nQuels comportements révèlent une culture inclusive ?\nQuels symptômes d'une culture d'entreprise faible ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Culture (sociologie)",
"description": "Comment prévenir le choc culturel ?\nQuelles pratiques favorisent une culture inclusive ?\nComment éviter une culture d'entreprise toxique ?\nQuelles actions pour renforcer la cohésion culturelle ?\nComment sensibiliser à la diversité culturelle ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Culture (sociologie)",
"description": "Comment améliorer une culture d'entreprise ?\nQuelles stratégies pour gérer le choc culturel ?\nComment promouvoir une culture positive ?\nQuels outils pour évaluer la culture d'une organisation ?\nComment intégrer la diversité dans la culture ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Culture (sociologie)",
"description": "Quelles conséquences d'une culture d'entreprise faible ?\nQuels risques d'un choc culturel prolongé ?\nComment une culture toxique affecte-t-elle la santé ?\nQuelles répercussions d'une mauvaise gestion culturelle ?\nQuels effets d'une culture non inclusive ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Culture (sociologie)",
"description": "Quels facteurs augmentent le choc culturel ?\nQuels éléments favorisent une culture toxique ?\nQuels risques liés à une culture d'entreprise homogène ?\nQuels facteurs influencent la diversité culturelle ?\nQuels éléments déclenchent des conflits culturels ?",
"url": "https://questionsmedicales.fr/mesh/D003469?mesh_terms=Drug+Development&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer une culture dans un groupe social ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'observation des comportements, des rituels et des valeurs partagées."
}
},
{
"@type": "Question",
"name": "Quels outils mesurent la culture d'une organisation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes, des interviews et des analyses de documents internes sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles méthodes étudient les changements culturels ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse historique, les études de cas et les enquêtes longitudinales sont courantes."
}
},
{
"@type": "Question",
"name": "Comment identifier les sous-cultures ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation des différences de valeurs et de comportements au sein d'un groupe aide."
}
},
{
"@type": "Question",
"name": "Quels indicateurs montrent une culture forte ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un engagement élevé, des valeurs partagées et une communication ouverte sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels signes montrent un choc culturel ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Désorientation, frustration, et sentiment d'aliénation sont des symptômes fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une culture toxique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un manque de communication, des conflits fréquents et un faible moral des employés sont des signes."
}
},
{
"@type": "Question",
"name": "Quels effets le stress culturel a-t-il ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut entraîner de l'anxiété, de la dépression et des problèmes de santé physique."
}
},
{
"@type": "Question",
"name": "Quels comportements révèlent une culture inclusive ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La diversité, l'égalité des chances et la valorisation des différences sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une culture d'entreprise faible ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un turnover élevé, une faible productivité et un manque d'innovation sont des symptômes."
}
},
{
"@type": "Question",
"name": "Comment prévenir le choc culturel ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Offrir des formations interculturelles avant un déplacement aide à prévenir le choc culturel."
}
},
{
"@type": "Question",
"name": "Quelles pratiques favorisent une culture inclusive ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des politiques de diversité, des formations et des événements culturels renforcent l'inclusion."
}
},
{
"@type": "Question",
"name": "Comment éviter une culture d'entreprise toxique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager la communication ouverte et traiter rapidement les conflits aide à prévenir la toxicité."
}
},
{
"@type": "Question",
"name": "Quelles actions pour renforcer la cohésion culturelle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des activités de groupe et des discussions sur les valeurs partagées renforce la cohésion."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser à la diversité culturelle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ateliers, des séminaires et des ressources éducatives sensibilisent à la diversité."
}
},
{
"@type": "Question",
"name": "Comment améliorer une culture d'entreprise ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des formations, des ateliers de team-building et une communication ouverte sont efficaces."
}
},
{
"@type": "Question",
"name": "Quelles stratégies pour gérer le choc culturel ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes d'orientation et de mentorat aident à atténuer le choc culturel."
}
},
{
"@type": "Question",
"name": "Comment promouvoir une culture positive ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager la reconnaissance, la collaboration et le feedback constructif favorise une culture positive."
}
},
{
"@type": "Question",
"name": "Quels outils pour évaluer la culture d'une organisation ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes de satisfaction et des audits culturels sont des outils utiles."
}
},
{
"@type": "Question",
"name": "Comment intégrer la diversité dans la culture ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mettre en place des politiques inclusives et des formations sur la diversité est essentiel."
}
},
{
"@type": "Question",
"name": "Quelles conséquences d'une culture d'entreprise faible ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une culture faible peut entraîner un turnover élevé, une faible productivité et des conflits."
}
},
{
"@type": "Question",
"name": "Quels risques d'un choc culturel prolongé ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un choc culturel prolongé peut mener à des problèmes de santé mentale et à l'isolement social."
}
},
{
"@type": "Question",
"name": "Comment une culture toxique affecte-t-elle la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer du stress, de l'anxiété et des problèmes de santé physique chez les employés."
}
},
{
"@type": "Question",
"name": "Quelles répercussions d'une mauvaise gestion culturelle ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise gestion peut entraîner des conflits internes, une baisse de moral et une perte de talents."
}
},
{
"@type": "Question",
"name": "Quels effets d'une culture non inclusive ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut créer des sentiments d'exclusion, de discrimination et nuire à la performance globale."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le choc culturel ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence de préparation, le manque de soutien social et des différences culturelles importantes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels éléments favorisent une culture toxique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un leadership autoritaire, une communication déficiente et des valeurs contradictoires favorisent la toxicité."
}
},
{
"@type": "Question",
"name": "Quels risques liés à une culture d'entreprise homogène ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une culture homogène peut mener à l'innovation limitée et à l'exclusion de talents divers."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la diversité culturelle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les politiques d'embauche, la sensibilisation et l'éducation influencent la diversité culturelle."
}
},
{
"@type": "Question",
"name": "Quels éléments déclenchent des conflits culturels ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des différences de valeurs, de croyances et de pratiques peuvent déclencher des conflits culturels."
}
}
]
}
]
}
The genesis of most older medicinal agents has generally been empirical. During the past one and a half centuries, at least in the Western countries, discovering and developing drugs has been primaril...
Pediatric extrapolation plays a key role in the availability of reliable pediatric use information in approved drug labeling. This review examined the use of pediatric extrapolation in studies submitt...
The substantial investments in human genetics and genomics made over the past three decades were anticipated to result in many innovative therapies. Here we investigate the extent to which these expec...
The concept of health equity-the attainment of the highest possible level of health for all members of society-requires equitable access to all aspects of healthcare, including pediatric drug developm...
The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 has led to an enormous surge of clinical research. So far, the speed and success rate of related drug development projects, espe...
Several vaccines and treatments under development in clinical phase III trials were selected for translational scoring with the translatability score. Six prospective and six retrospective case studie...
A significant correlation between the translatability scores and the clinical outcomes in translation was found, as judged on the basis of positive/intermediate/negative endpoint studies or market app...
The score detects strengths and weaknesses of a given project, resulting in the opportunity of selective amelioration of a project, as well as prospective portfolio risk balancing. Its substantial pre...
Artificial intelligence (AI)-based predictive models are being used to foster a precision medicine approach to treat complex chronic diseases such as autoimmune and autoinflammatory disorders (AIIDs)....
Membrane transporters are now widely recognized for their role in the absorption, distribution, clearance, and elimination of drugs. The organic cation transporters (OCTs, SLC22A) are expressed in the...
An overview of the role of OCTs in drug disposition is presented. Genetic variation in OCTs and the effects on PK and drug response were discussed....
Clinical studies demonstrated significance of OCT1 and OCT2 in the hepatic uptake and renal secretion of drug, respectively. These mechanisms are important in determining the systemic PK and tissue ex...
The regulatory standards of the United States Food and Drug Administration (FDA) require substantial evidence of effectiveness from adequate and well-controlled trials, for drugs developed in both adu...
The recent increase in clinical research on the potential therapeutic uses of classic psychedelics has prompted the need to revisit the assessment of the abuse potential of these drugs. The term "clas...
This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein-protein interactions remains c...